Cargando…
Δ133p53/FLp53 Predicts Poor Clinical Outcome in Esophageal Squamous Cell Carcinoma
BACKGROUND: p53 isoform Δ133p53 is directly transactivated by p53 and antagonizes p53 activities in cancer progression. However, its correlation with prognosis and cancer recurrence in esophageal squamous cell carcinoma (ESCC) is still unclear. PATIENTS AND METHODS: Expression of Δ133p53 and Δ133p53...
Autores principales: | Tu, Qimin, Gong, Hongjian, Yuan, Chunhui, Liu, Gao, Huang, Jinqi, Li, Zhichao, Luo, Jianfei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443442/ https://www.ncbi.nlm.nih.gov/pubmed/32884352 http://dx.doi.org/10.2147/CMAR.S263559 |
Ejemplares similares
-
Δ113p53/Δ133p53: survival and integrity
por: Chen, Jun, et al.
Publicado: (2015) -
The Δ133p53 Isoforms, Tuners of the p53 Pathway
por: Joruiz, Sebastien M., et al.
Publicado: (2020) -
p73 coordinates with Δ133p53 to promote DNA double-strand break repair
por: Gong, Hongjian, et al.
Publicado: (2018) -
The RNA helicase p68 modulates expression and function of the Δ133 isoform(s) of p53, and is inversely associated with Δ133p53 expression in breast cancer
por: Moore, Hayley C, et al.
Publicado: (2010) -
Δ122p53, a mouse model of Δ133p53α, enhances the tumor-suppressor activities of an attenuated p53 mutant
por: Slatter, T L, et al.
Publicado: (2015)